Evidence map›Paper›PMID 29097919›Full record

ArticleContrast media & molecular imaging2017

Preliminary

In Ok Ko, Ki-Hye Jung, Mi Hyun Kim, Kyeung Jun Kang, Kyo Chul Lee, Kyeong Min Kim, Insup Noh, Yong Jin Lee, Sang Moo Lim, Jung Young Kim and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Contrast media & molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

In Ok KoDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.ORCID 0000-0003-1193-8363
Ki-Hye JungDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Mi Hyun KimDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Kyeung Jun KangDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.ORCID 0000-0001-5741-6339
Kyo Chul LeeDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Kyeong Min KimDivision of Medical Radiation Equipment, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.ORCID 0000-0001-6284-0644
Insup NohDepartment of Chemical & Biomolecular Engineering, Seoul National University of Science & Technology, Seoul, Republic of Korea.
Yong Jin LeeDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Sang Moo LimDepartment of Nuclear Medicine, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
Jung Young KimDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.ORCID 0000-0002-0755-3893
Ji-Ae ParkDivision of RI-Convergence Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.ORCID 0000-0001-6109-802X
Korea Institute of Radiological and Medical Sciences · KRSeoul National University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The thymidine analogue 3'-deoxy-3'-[

Indexed as

Cell ProliferationAnimalsCell Line, TumorDideoxynucleosidesFluorine-19 Magnetic Resonance ImagingHeterograftsHumansMCF-7 CellsMiceNeoplasmsalovudineDideoxynucleosides

Identifiers

PMID29097919
PMCPMC5634584
OpenAlexW2759913311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.